US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Women's Health Market Research Reports & Industry Analysis

Women’s health is a perspective of prevention and treatment that looks at health concerns unique to females. Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. Recently there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts.
In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change. Gaps remain, both in research areas and in the application of results to benefit women in general and across multiple population groups.

Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.

Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.

RSS Feeds

Women's Health Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Global Cervical Cancer Drug Industry Report 2015
7/15/2015 | published by: QYResearch Group
... definitions, classifications, applications and industry chain structure. The Cervical Cancer Drug market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are ...  |  read more...
USD 2,800
Global Contraceptive Devices Market 2015-2019
7/15/2015 | published by: TechNavio - Infiniti Research Ltd.
... sterilization for men (vasectomy). Temporary methods are hormonal and non-hormonal. Hormonal methods include contraceptive transdermal patches, oral contraceptive pills, hormonal IUDs, vaginal rings, and vaginal implants. Non-hormonal methods include withdrawal methods, diaphragms, condoms, sponges, cervical ...  |  read more...
USD 2,500
Global Contraceptives Market Industry Report 2015
7/15/2015 | published by: QYResearch Group
... applications and industry chain structure.The Contraceptives Market market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as ...  |  read more...
USD 2,800
China Cervical Cancer Drug Industry Report 2015
7/15/2015 | published by: QYResearch Group
... definitions, classifications, applications and industry chain structure. The Cervical Cancer Drug market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are ...  |  read more...
USD 3,200
Global Contraceptive Devices Industry Report 2015
7/23/2015 | published by: QYResearch Group
... applications and industry chain structure. The Contraceptive Devices market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well ...  |  read more...
USD 2,800
Global Condom Industry Report 2015
7/29/2015 | published by: QYResearch Group
... industry chain structure.The Condom market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and ...  |  read more...
USD 2,800
United States Intrauterine Contraceptive Devices Industry Report 2015
7/30/2015 | published by: QYResearch Group
... including definitions, classifications, applications and industry chain structure. The Intrauterine Contraceptive Devices market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and ...  |  read more...
USD 3,800
Uterine cancer Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... therapies for Uterine cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 670
Global Cervical Cancer Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Cervical Cancer Partnering 2010-2015 provides understanding and access to the cervical cancer partnering deals and agreements entered into by ...  |  read more...
USD 1,495
Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015
6/25/2015 | published by: GlobalData
... report provides top line data relating to the clinical trials on Human Papillomavirus Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ...  |  read more...
USD 2,500
Breast Cancer Treatment Drug Markets in China
7/1/2015 | published by: Asia Market Information & Development Company
... to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new ...  |  read more...
USD 4,000
Cervical Cancer Treatment Drugs Markets in China
7/1/2015 | published by: Asia Market Information & Development Company
... to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new ...  |  read more...
USD 4,000
Ovarian Cancer Treatment Drugs Markets in China
7/1/2015 | published by: Asia Market Information & Development Company
... to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new ...  |  read more...
USD 4,000
Global Breast Cancer Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Breast Cancer Partnering 2010-2015 provides understanding and access to the breast cancer partnering deals and agreements entered into by ...  |  read more...
USD 1,995
Global Ovarian Cancer Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Ovarian Cancer Partnering 2010-2015 provides understanding and access to the ovarian cancer partnering deals and agreements entered into by ...  |  read more...
USD 1,495
2015-2019 World Papillomavirus Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers - US, Europe (France, Germany, Italy, Spain, UK), Japan
6/23/2015 | published by: VPGMarketResearch.com
... report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition to test volume and sales ...  |  read more...
USD 4,350
2015-2019Global Pap Smear/HPV Market: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape - US, Europe (France, Germany, Italy, Spain, UK), Japan
6/22/2015 | published by: VPGMarketResearch.com
... the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ...  |  read more...
USD 5,450
Endometrial Cancer - Pipeline Review, H1 2015
5/29/2015 | published by: Global Markets Direct
... therapeutic development for Endometrial Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Premenstrual Dysphoric Disorder (PMDD) - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Premenstrual Dysphoric Disorder (PMDD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Post Menopausal Osteoporosis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Post Menopausal Osteoporosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
2015 Strategies in the Chlamydia Diagnostic Testing Market
5/27/2015 | published by: VPGMarketResearch.com
... report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each country, in addition to test ...  |  read more...
USD 4,350
Uterine Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Uterine Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Uterine Cancer- Pipeline ...  |  read more...
USD 1,250
Breast Cancer Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... and metastatic setting, the overall survival remains below five years. There are today 573 companies plus partners developing 699 drugs targeting breast cancer in development. In addition, there are 8 suspended drugs and the accumulated ...  |  read more...
USD 6,750
Ovarian Cancer Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... an important secondary indication for existing and pipeline drugs. There are today 314 companies plus partners developing 418 drugs targeting ovarian cancer in development. In addition, there are 6 suspended drugs and the accumulated number ...  |  read more...
USD 6,750
Uterine Fibroids-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Uterine Fibroids Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Uterine Fibroids- Pipeline ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10